CrushSCI.com
159.2Average days
160Median days
25Fastest days
301Longest days
1,3632025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

25 days

Structured reporting of diagnostic hysteroscopy findings in women with reproductive disorders: an ESGE–ESHRE–IFFS international consensus†ǂ

Authors
International Hysteroscopy Working Group of ESGE, ESHRE and IFFS https://orcid.org/0000-0002-7813-7993CatenaUhttps://orcid.org/0000-0001-6651-0554GrimbizisGhttps://orcid.org/0000-0003-0448-3540ArenaACampoRhttps://orcid.org/0000-0002-8334-9050De AngelisChttps://orcid.org/0000-0001-6485-5735Di Spiezio SardoAhttps://orcid.org/0000-0002-9817-9445FekiAhttps://orcid.org/0000-0002-6463-1018FernandezHHortonMhttps://orcid.org/0000-0002-3094-4892MocanuEhttps://orcid.org/0000-0002-8521-3675PachecoL Ahttps://orcid.org/0000-0002-3952-5483PadosGhttps://orcid.org/0009-0002-2012-4695VereczkeyAhttps://orcid.org/0000-0001-7079-6890SaravelosShttps://orcid.org/0000-0002-2824-5435VitaglianoAhttps://orcid.org/0000-0002-6536-453XAciénMhttps://orcid.org/0000-0002-6077-9840GianaroliL; U Catena; G Grimbizis; A Arena; R Campo; C De Angelis; A Di Spiezio Sardo; A Feki; H Fernandez; M Horton; E Mocanu; L A Pacheco; G Pados; A Vereczkey; S Saravelos; A Vitagliano; M Acién; L Gianaroli; U Catena; G Grimbizis; A Arena; R Campo; C De Angelis; A Di Spiezio Sardo; A Feki; H Fernandez; M Horton; E Mocanu; L A Pacheco; G Pados; A Vereczkey; S Saravelos; A Vitagliano; M Acién; L GianaroliShow moreShow less
Affiliations
1. Gynaecology Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; 2. 1st Department of Obstetrics and Gynecology, Medical Faculty, Aristotle University of Thessaloniki, Thessaloniki, Greece; 3. Division of Gynecology and Human Reproduction Physiopathology, IRCCS S.Orsola Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 4. Life Expert Centre, Leuven, Belgium; 5. Department of Maternal and Child Health and Urological Sciences, “Sapienza” University of Rome, Rome, Italy; 6. Department of Public Health, School of Medicine, University of Naples Federico II, Naples, Italy; 7. Department of Obstetrics and Gynecology, HFR Fribourg—Hôpital cantonal, Fribourg, Switzerland; 8. University Paris-Saclay, Paris, France; 9. Pregna Medicina Reproductiva, Buenos Aires, Argentina; 10. Department of Reproductive Medicine, Rotunda Hospital and RCSI, Dublin, Ireland; 11. Obstetrics and Gynecology Department, Reproductive Surgery Unit, Hospital Quirón, Malaga, Spain; 12. Versys Clinics-Human Reproduction Institute, Budapest, Hungary; 13. Hammersmith Hospital, Imperial College, London, UK; 14. Unit of Obstetrics and Gynaecology, Department of Interdisciplinary Medicine (DIM), University of Bari “Aldo Moro”, Policlinico of Bari, Bari, Italy; 15. Obstetrics and Gynecology Service, San Juan University Hospital, Division of Gynecology, Miguel Hernández University, Alicante, Spain; 16. International Institute of Reproductive Medicine—IIRM—Lugano, Lugano, Switzerland; 17. Interdisciplinary Institute of Reproductive Medicine—IIRM—Bologna, Bologna, ItalyShow moreShow less
Source PDF DOI Publisher page
169 days

A double-blind multi-centre randomised placebo-controlled trial of doxycycline in women with recurrent miscarriage and chronic endometritis defined by CD138 positive stromal cells

Authors
J Odendaal; N Black; K Fishwick; J Thornton; K Makwana; L Ewington; K Larsen; A Hawkes; C Leeson; J Fisher; R Lall; J Guck; A Coomarasamy; I Granne; M Underwood; G Bouliotis; S QuenbyShow moreShow less
Affiliations
1. Division of Biomedical Sciences, Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick, Coventry, UK; 2. University Hospitals Coventry & Warwickshire, Coventry, UK; 3. Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK; 4. Tommy’s National Centre for Miscarriage Research, Nuffield Department of Women’s and Reproductive Health, Medical Sciences Division, University of Oxford, Oxford, UK; 5. Nuffield Department of Women’s and Reproductive Health, Medical Sciences Division, University of Oxford, Oxford, UKShow moreShow less
Official full-text evidence DOI Publisher page
301 days

Nanomolar vanillin, an e-cigarette flavorant, appears to disrupt pluripotency and promote endodermal differentiation in human embryonic stem cells via TRPV4 activation

Authors
Shabnam Etemadi; Prue TalbotShow moreShow less
Affiliations
1. Department of Bioengineering, University of California, Riverside, CA, USA; 2. Department of Molecular, Cell and Systems Biology, University of California, Riverside, CA, USAShow moreShow less
Official full-text evidence DOI Publisher page
82 days

Mitochondria-targeted therapeutic strategies in assisted reproduction: challenges and potential solutions

Authors
Raziye Melike Yildirim; Gizem Nur Sahin; Richard T Scott; Emre SeliShow moreShow less
Affiliations
1. Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine , New Haven, CT,Show moreShow less
Source PDF DOI Publisher page
234 days

From evidence to vision–from Developments to Directions

Authors
Kirstine Kirkegaard; Emma J Andrew; Andrew C Williams; Chris BarrattShow moreShow less
Affiliations
1. Co-Editor-in-Chief, Human Reproduction; 2. Associate Managing Editor, ESHRE Journals; 3. Senior Managing Editor, ESHRE JournalsShow moreShow less
Source PDF DOI Publisher page
113 days

Increased risk of congenital anomalies after fertility treatment is partially mediated by multiple birth: a population-based cohort study

Authors
B M Milne; M P Velez; J Shellenberger; S B BroglyShow moreShow less
Affiliations
1. Department of Public Health Sciences, Queen’s University, Kingston, ON, Canada; 2. Department of Obstetrics and Gynecology, McGill University, Montreal, QC, Canada; 3. ICES, Kingston, ON, Canada; 4. Department of Surgery, Queen’s University, Kingston, ON, CanadaShow moreShow less
Official full-text evidence DOI Publisher page

FAQ

How long does HUMAN REPRODUCTION take to review a manuscript?

As of 2026-11-19, CrushSCI has 10 complete review records for HUMAN REPRODUCTION. The fastest paper went from submission to acceptance in 25 days (Structured reporting of diagnostic hysteroscopy findings in women with reproductive disorders: an ESGE–ESHRE–IFFS international consensus†ǂ, received 2026-07-17, accepted 2026-08-11); the slowest took 301 days. The average is 159.2 days and the median is 160 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.